ictc: session 3b - management of car t cell toxicities
Published 5 years ago • 71 plays • Length 22:28Download video MP4
Download video MP3
Similar videos
-
22:31
ictc session 3b car t cells experience from hangzhou
-
25:18
ictc: session 3b - car t cells experience from spain
-
20:15
ictc: session 3a - update on the results of car t cells in all
-
47:52
gut microbiome correlates of response and toxicity following anti cd19 car t cell therapy
-
23:41
ictc session 3a update on the results of car t cells in myeloma
-
49:10
car t cell therapy for relapsed lymphoma: journey from being a patient to a survivor
-
45:36
autologous transplant vs chimeric antigen rec. t-cell therapy for relapsed dlbcl in partial rem.
-
40:15
cd19 targeted car t cells in refractory systemic lupus erythematosus
-
34:07
outcomes in patients treated w/ chimeric antigen receptor t-cell therapy admitted to intensive care
-
23:57
iach 2019: car t cell therapy - how to set up a clinical unit
-
1:53
car-t cells in lymphoid diseases: the patient journey
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
3:55
side effects of car t-cell therapy and their management
-
51:16
bench at bedside models facilitate car-t cell supply chain
-
55:10
car-t cell therapy: now and in 2030 | laboratory medicine and pathology in individualized medicine
-
0:48
how to choose and prepare patients for car t-cell therapy?
-
32:04
htlv-1 associated malignancies: from diagnosis to treatment
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma